Close
Richard Zimmerman

Professor

Education

Affiliations

Projects

Papers

Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ. (2020). Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. Populations. American journal of preventive medicine

Smith ER, Fry AM, Hicks LA, Fleming-Dutra KE, Flannery B, Ferdinands J, Rolfes MA, Martin ET, Monto AS, Zimmerman RK, Nowalk MP, Jackson ML, McLean HQ, Olson SC, Gaglani M, Patel MM. (2020). Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ. (2020). Cost-Effectiveness of Pneumococcal Vaccination Policies and Uptake Programs in US Older Populations. Journal of the American Geriatrics Society

Moehling KK, Zimmerman RK, Nowalk MP, Jeng Lin C, Martin JM, Alcorn JF, Susick M, Burroughs A, Holiday C, Flannery B, Levine MZ. (2020). A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children. Vaccine

Balasubramani GK, Nowalk MP, Sax TM, Suyama J, Bobyock E, Rinaldo CR Jr., Martin ET, Monto AS, Jackson ML, Gaglani MJ, Flannery B, Chung JR, Zimmerman RK. (2020). Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Influenza and other respiratory viruses

Alcorn JF, Avula R, Chakka AB, Schwarzmann WE, Nowalk MP, Lin CJ, Ortiz MA, Horne WT, Chandran UR, Nagg JP, Zimmerman RK, Cole KS, Moehling KK, Martin JM. (2020). Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine. Human vaccines & immunotherapeutics

Balasubramani GK, Choi WS, Nowalk MP, Zimmerman RK, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Jackson ML, Jackson LA, Chung JR, Spencer S, Fry AM, Patel M, Flannery B,. (2020). Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. Vaccine

Tenforde MW, Chung J, Smith ER, Talbot HK, Trabue CH, Zimmerman RK, Silveira FP, Gaglani M, Murthy K, Monto AS, Martin ET, McLean HQ, Belongia EA, Jackson LA, Jackson ML, Ferdinands JM, Flannery B, Patel MM. (2020). Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Zimmerman RK, South-Paul JE, Poland GA. (2020). Rationing of civilian COVID-19 vaccines while supplies are limited. The Journal of infectious diseases

Kim SS, Flannery B, Foppa IM, Chung JR, Nowalk MP, Zimmerman RK, Gaglani M, Monto AS, Martin ET, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Patel M. (2020). Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Balasubramani GK, Nowalk MP, Clarke LG, Lyons JA, Dauer K, Silveira F, Middleton DB, Yassin M, Zimmerman RK. (2020). Using Capture-Recapture Methods to Estimate Local Influenza Hospitalization Incidence Rates. medRxiv : the preprint server for health sciences

Martin ET, Cheng C, Petrie JG, Alyanak E, Gaglani M, Middleton DB, Ghamande S, Silveira FP, Murthy K, Zimmerman RK, Monto AS, Trabue C, Talbot HK, Ferdinands JM,. (2020). Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). The Journal of infectious diseases

Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, Spencer S, Fry AM, Flannery B. (2020). Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Smith KJ, France G, Nowalk MP, Raviotta JM, DePasse J, Wateska A, Shim E, Zimmerman RK. (2019). Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis. American Journal of Preventive Medicine, 56(4)

DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST. (2019). Exploring the potential public health benefits of universal influenza vaccine. Human vaccines & immunotherapeutics, 15(12)

Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ. (2019). Cost-Effectiveness of Pneumococcal Vaccination and Uptake Improvement Programs in Underserved and General Population Adults Aged < 65 Years. Journal of community health

Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ. (2019). Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64 years compared to the US general population. Vaccine, 37(14)

Rolfes MA, Flannery B, Chung JR, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman RK, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, Kirley PD, Lynfield R, Monroe ML, Spencer M, Spina N, Talbot HK, Thomas A, Torres SM, Yousey-Hindes K, Singleton JA, Patel M, Reed C, Fry AM, . (2019). Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(11)

Nowalk MP, Wateska AR, Lin CJ, Schaffner W, Harrison LH, Zimmerman RK, Smith KJ. (2019). Racial Disparities in Adult Pneumococcal Vaccination Indications and Pneumococcal Hospitalizations in the U.S. Journal of the National Medical Association

Havers FP, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, Fry AM, Flannery B. (2019). Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68(10)

Wateska AR, Nowalk MP, Zimmerman RK, Smith KJ, Lin CJ. (2018). Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis. BMC infectious diseases, 18(1)

Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Griffin MR, Keipp Talbot H, Treanor JJ, Wentworth DE, Fry AM. (2018). Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. The Journal of infectious diseases, 218(2)

Balasubramani GK, Saul S, Nowalk MP, Middleton DB, Ferdinands JM, Zimmerman RK. (2018). Does influenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias. Human vaccines & immunotherapeutics, 15(1)

Ferdinands JM, Gaglani M, Martin ET, Middleton D, Monto AS, Murthy K, Silveira FP, Talbot HK, Zimmerman R, Alyanak E, Strickland C, Spencer S, Fry AM, . (2019). Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). The Journal of infectious diseases, 220(8)

Tajgardoon M, Wagner MM, Visweswara S, Zimmerman RK. (2018). A Novel Representation of Vaccine Efficacy Trial Datasets for Use in Computer Simulation of Vaccination Policy. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, (2017)

Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, Barnes JR, Spencer S, Fry AM. (2018). Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. MMWR. Morbidity and mortality weekly report, 67(6)

Nowalk MP, Balasubramani GK, Zimmerman RK, Bear TM, Sax T, Eng H, Susick M, Ford SE. (2019). Influenza Vaccine Intention After a Medically Attended Acute Respiratory Infection. Health promotion practice, 20(4)

Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK, Smith KJ. (2018). An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysis. Human Vaccines & Immunotherapeutics, 15(4)

Shang M, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Fry AM, Flannery B. (2018). Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine, 36(52)

Shim E, Smith KJ, Nowalk MP, Raviotta JM, Brown ST, DePasse J, Zimmerman RK. (2018). Impact of seasonal influenza vaccination in the presence of vaccine interference. Vaccine, 36(6)

Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM, . (2019). Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68(11)

Appiah GD, Chung JR, Flannery B, Havers FP, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Gaglani M, Murthy K, Jackson LA, Jackson ML, McLean HQ, Belongia EA, Fry AM. (2019). Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011-12-2015-16. Influenza and other respiratory viruses, 13(2)

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B. (2018). Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine, 36(10)

France G, Wateska AR, Nowalk MP, DePasse J, Raviotta JM, Shim E, Zimmerman RK, Smith KJ. (2018). Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults. Innovation in Aging, 2(3)

Havers FP, Hicks LA, Chung JR, Gaglani M, Murthy K, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Flannery B, Fry AM. (2018). Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons. JAMA network open, 1(2)

Martin JM, Avula R, Nowalk MP, Lin CJ, Horne WT, Chandran UR, Nagg JP, Zimmerman RK, Cole KS, Alcorn JF. (2018). Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children. Open forum infectious diseases, 5(11)

Zimmerman RK, Raviotta JM, Nowalk MP, Moehling KK, Reis EC, Humiston SG, Lin CJ. (2017). Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. Vaccine, 35(45)

Moehling KK, Nowalk MP, Lin CJ, Bertolet M, Ross TM, Carter CE, Susick M, Saul SG, Kaynar AM, Bromberger JT, Zimmerman RK. (2018). The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age. Human vaccines & immunotherapeutics, 14(2)

Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson ML, Monto AS, Martin ET, Belongia EA, McLean HQ, Fry AM, Havers FP. (2018). Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(7)

Smith KJ, Nowalk MP, Wateska A, Brown ST, DePasse JV, Raviotta JM, Shim E, Zimmerman RK. (2017). Potential Consequences of Not Using Live Attenuated Influenza Vaccine. American journal of preventive medicine, 53(4)

Smith KJ, Nowalk MP, Lin CJ, Zimmerman RK. (2017). Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old. Human Vaccines & Immunotherapeutics, 13(10)

Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B. (2018). Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. Vaccine, 36(4)

Cole KS, Martin JM, Horne WT, Lin CJ, Nowalk MP, Alcorn JF, Zimmerman RK. (2017). Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine. Vaccine, 35(49 Pt B)

DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST. (2017). Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study. Vaccine, 35(32)

DePasse JV, Smith KJ, Raviotta JM, Shim E, Nowalk MP, Zimmerman RK, Brown ST. (2017). Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study. American journal of epidemiology, 185(9)

Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Wateska A, France GS, Zimmerman RK. (2017). Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults. Vaccine, 35(42)

Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK. (2017). Reply to: Estimating the Full Value of High-Dose Influenza Vaccine. Journal of the American Geriatrics Society, 65(9)

Smith KJ, Zimmerman RK, Nowalk MP, Lin CJ. (2017). Cost-Effectiveness of the 4 Pillars Practice Transformation Program to Improve Vaccination of Adults Aged 65 and Older. Journal of the American Geriatrics Society, 65(4)

Levine MZ, Martin JM, Gross FL, Jefferson S, Cole KS, Archibald CA, Nowalk MP, Susick M, Moehling K, Spencer S, Chung JR, Flannery B, Zimmerman RK. (2016). Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination. Clinical and vaccine immunology : CVI, 23(10)

Zimmerman RK, Moehling KK, Lin CJ, Zhang S, Raviotta JM, Reis EC, Humiston SG, Nowalk MP. (2017). Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program. Vaccine, 35(1)

Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR. (2016). Classification and Regression Tree (CART) analysis to predict influenza in primary care patients. BMC infectious diseases, 16(1)

Zimmerman RK, Brown AE, Pavlik VN, Moehling KK, Raviotta JM, Lin CJ, Zhang S, Hawk M, Kyle S, Patel S, Ahmed F, Nowalk MP. (2017). Using the 4 Pillars Practice Transformation Program to Increase Pneumococcal Immunizations for Older Adults: A Cluster-Randomized Trial. Journal of the American Geriatrics Society, 65(1)

Shim E, Brown ST, DePasse J, Nowalk MP, Raviotta JM, Smith KJ, Zimmerman RK. (2016). Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine. American journal of preventive medicine, 51(3)

Smith KJ, Raviotta JM, DePasse JV, Brown ST, Shim E, Patricia Nowalk M, Zimmerman RK. (2016). Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S. American Journal of Preventive Medicine, 50(5)

Kaynar AM, Nowalk MP, Lin CJ, Moehling KK, Susick M, Bakalov V, Pitt BR, Bain DJ, Ross TM, Saul SG, Raymund M, Zimmerman RK. (2016). Are plasma mineral levels related to antibody response to influenza vaccination in older adults?. Human vaccines & immunotherapeutics, 12(4)

Michaelidis CI, Fine MJ, Lin CJ, Linder JA, Nowalk MP, Shields RK, Zimmerman RK, Smith KJ. (2016). The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis. BMC Infectious Diseases, 16(1)

Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B, , . (2016). 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63(12)

Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM, Moehling KK, Hawk M, Ricci EM, Middleton DB, Patel S, South-Paul JE, Zimmerman RK. (2016). Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC infectious diseases, 16(1)

Nowalk MP, Lin CJ, Pavlik VN, Brown AE, Zhang S, Moehling KK, Raviotta JM, South-Paul JE, Hawk M, Ricci EM, Middleton DB, Patel SA, Ahmed F, Zimmerman RK. (2016). Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial. Vaccine, 34(41)

Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK. (2016). Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults. Journal of the American Geriatrics Society, 64(10)

Lin CJ, Nowalk MP, Raymund M, Sweeney PM, Zimmerman RK. (2016). Association of State Laws and Healthcare Workers' Influenza Vaccination Rates. Journal of the National Medical Association, 108(1)

Zimmerman RK, Rinaldo CR, Nowalk MP, Balasubramani GK, Moehling KK, Bullotta A, Eng HF, Raviotta JM, Sax TM, Wisniewski S. (2015). Viral infections in outpatients with medically attended acute respiratory illness during the 2012-2013 influenza season. BMC infectious diseases, (15)

Lee BY, Bartsch SM, Brown ST, Cooley P, Wheaton WD, Zimmerman RK. (2015). Quantifying the economic value and quality of life impact of earlier influenza vaccination. Medical care, 53(3)

Zimmerman RK, Lin CJ, Raviotta JM, Nowalk MP. (2015). Do vitamin D levels affect antibody titers produced in response to HPV vaccine?. Human vaccines & immunotherapeutics, 11(10)

Zimmerman RK, Rinaldo CR, Nowalk MP, Gk B, Thompson MG, Moehling KK, Bullotta A, Wisniewski S. (2014). Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season. Influenza and other respiratory viruses, 8(4)

Nace DA, Lin CJ, Ross TM, Saracco S, Churilla RM, Zimmerman RK. (2015). Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. The Journal of infectious diseases, 211(12)

Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. (2014). Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States. BMC Public Health, (14)

Raviotta JM, Nowalk MP, Lin CJ, Huang HH, Zimmerman RK. (2016). Using Facebook™ to Recruit College-Age Men for a Human Papillomavirus Vaccine Trial. American journal of men's health, 10(2)

Nowalk MP, Lin CJ, Hannibal K, Reis EC, Gallik G, Moehling KK, Huang HH, Allred NJ, Wolfson DH, Zimmerman RK. (2014). Increasing childhood influenza vaccination: a cluster randomized trial. American journal of preventive medicine, 47(4)

Ross TM, Lin CJ, Nowalk MP, Huang HH, Spencer SM, Shay DK, Sambhara S, Sundaram ME, Friedrich T, Sauereisen S, Bloom CE, Zimmerman RK. (2014). Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age. Human vaccines & immunotherapeutics, 10(5)

Zimmerman RK, Rinaldo CR, Nowalk MP, Balasubramani GK, Thompson MG, Bullotta A, Susick M, Wisniewski S. (2014). Detection of influenza virus infection using two PCR methods. Advances in virology, (2014)

Zimmerman RK, Nowalk MP, Lin CJ, Hannibal K, Moehling KK, Huang HH, Matambanadzo A, Troy J, Allred NJ, Gallik G, Reis EC. (2014). Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care. Vaccine, 32(29)

Zimmerman RK. (2014). Increasing engagement of clinicians in adult immunizations: reflections on a decade and a half of research. Vaccine, 32(52)

Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. (2017). Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 16(2)

Smith KJ, Nowalk MP, Raymund M, Zimmerman RK. (2013). Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults. Vaccine, 31(37)

Nowalk MP, Lin CJ, Raymund M, Bialor J, Zimmerman RK. (2013). Impact of hospital policies on health care workers' influenza vaccination rates. American journal of infection control, 41(8)

Smith KJ, Wateska AR, Nowalk MP, Raymund M, Lee BY, Zimmerman RK. (2013). Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults. American Journal of Preventive Medicine, 44(4)

Nowalk MP, Nolan BA, Nutini J, Ahmed F, Albert SM, Susick M, Zimmerman RK. (2013). Success of the 4 pillars toolkit for influenza and pneumococcal vaccination in adults. Journal for healthcare quality : official publication of the National Association for Healthcare Quality, 36(6)

Michaelidis CI, Zimmerman RK, Nowalk MP, Fine MJ, Smith KJ. (2014). Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults. Journal of general internal medicine, 29(4)

Zimmerman RK, Lin CJ, Raymund M, Bialor J, Sweeney PM, Nowalk MP. (2013). Hospital policies, state laws, and healthcare worker influenza vaccination rates. Infection control and hospital epidemiology, 34(8)

Zimmerman RK, Raviotta J. (2013). Steps for clinicians and public health officials to take to reach persons of faith, for the sake of protecting all against vaccine-preventable diseases. Vaccine, 31(16)

Smith KJ, Wateska A, Nowalk MP, Raymund M, Lee BY, Zimmerman RK, Fine MJ. (2013). Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia. Journal of General Internal Medicine, 28(9)

Zimmerman RK. (2013). Ethical analyses of institutional measures to increase health care worker influenza vaccination rates. Vaccine, 31(52)

Lin CJ, Zimmerman RK, Smith KJ. (2013). Cost-effectiveness of pneumococcal and influenza vaccination standing order programs. The American journal of managed care, 19(1)

Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. (2013). Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 16(2)

Zimmerman RK, Wiringa AE, Nowalk MP, Lin CJ, Rousculp MD, Mitgang EA, Lee BY. (2012). The comparative value of various employer-sponsored influenza vaccination clinics. Journal of occupational and environmental medicine, 54(9)

Nowalk MP, Nutini J, Raymund M, Ahmed F, Albert SM, Zimmerman RK. (2012). Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: a multimodal pilot project. Vaccine, 30(41)

Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK. (2012). Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA, 307(8)

Bhat-Schelbert K, Lin CJ, Matambanadzo A, Hannibal K, Nowalk MP, Zimmerman RK. (2012). Barriers to and facilitators of child influenza vaccine - perspectives from parents, teens, marketing and healthcare professionals. Vaccine, 30(14)

Song Y, Tai JH, Bartsch SM, Zimmerman RK, Muder RR, Lee BY. (2012). The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients. Vaccine, 30(24)

Nowalk MP, Clinch CR, Tarn DM, Chang T, Ncube CN, Troy JA, Zimmerman RK. (2012). Shots by STFM: value of immunization software to family medicine residency directors: a CERA study. Family medicine, 44(10)

Lin CJ, Nowalk MP, Zimmerman RK. (2012). Estimated costs associated with improving influenza vaccination for health care personnel in a multihospital health system. Joint Commission journal on quality and patient safety, 38(2)

Lee BY, Tai JH, McGlone SM, Bailey RR, Wateska AR, Zimmer SM, Zimmerman RK, Wagner MM. (2012). The potential economic value of a 'universal' (multi-year) influenza vaccine. Influenza and other respiratory viruses, 6(3)

Zimmerman RK, Albert SM, Nowalk MP, Yonas MA, Ahmed F. (2011). Use of standing orders for adult influenza vaccination a national survey of primary care physicians. American journal of preventive medicine, 40(2)

Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. (2011). Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine, 29(19)

Lee BY, Bacon KM, Donohue JM, Wiringa AE, Bailey RR, Zimmerman RK. (2011). From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine, 29(11)

Lee BY, Brown ST, Bailey RR, Zimmerman RK, Potter MA, McGlone SM, Cooley PC, Grefenstette JJ, Zimmer SM, Wheaton WD, Quinn SC, Voorhees RE, Burke DS. (2011). The benefits to all of ensuring equal and timely access to influenza vaccines in poor communities. Health affairs (Project Hope), 30(6)

Lee BY, Tai JH, Bailey RR, McGlone SM, Wiringa AE, Zimmer SM, Smith KJ, Zimmerman RK. (2011). Economic model for emergency use authorization of intravenous peramivir. The American journal of managed care, 17(1)

Ross T, Zimmer S, Burke D, Crevar C, Carter D, Stark J, Giles B, Zimmerman R, Ostroff S, Lee B. (2010). Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. PLoS currents, (2)

Lee BY, Brown ST, Cooley P, Grefenstette JJ, Zimmerman RK, Zimmer SM, Potter MA, Rosenfeld R, Wheaton WD, Wiringa AE, Bacon KM, Burke DS. (2010). Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination. American journal of preventive medicine, 39(5)

Lee BY, McGlone SM, Bailey RR, Wiringa AE, Zimmer SM, Smith KJ, Zimmerman RK. (2010). To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling. PLoS One, 5(6)

Lee BY, Brown ST, Korch GW, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Bailey RR, Assi TM, Burke DS. (2010). A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine, 28(31)

Lin CJ, Nowalk MP, Toback SL, Rousculp MD, Raymund M, Ambrose CS, Zimmerman RK. (2010). Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine, 28(48)

Zimmerman RK, Nowalk MP, Lin CJ, Fox DE, Ko FS, Wettick E, Cost G, Hand L, Hayes J, Michaels M. (2010). Randomized trial of an alternate human papillomavirus vaccine administration schedule in college-aged women. Journal of women's health (2002), 19(8)

Lee BY, Bailey RR, Wiringa AE, Afriyie A, Wateska AR, Smith KJ, Zimmerman RK. (2010). Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine, 28(37)

Smith KJ, Lee BY, Nowalk MP, Raymund M, Zimmerman RK. (2010). Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds. Vaccine, 28(48)

Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK. (2010). Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine, 28(39)

Smith KJ, Raymund M, Nowalk MP, Roberts MS, Zimmerman RK. (2010). Cost-effectiveness of pneumococcal polysaccharide vaccine among healthcare workers during an influenza pandemic. The American journal of managed care, 16(3)

Lee BY, Brown ST, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Assi TM, Furphy TJ, Wagener DK, Burke DS. (2010). A computer simulation of employee vaccination to mitigate an influenza epidemic. American journal of preventive medicine, 38(3)

Nowalk MP, Lin CJ, Toback SL, Rousculp MD, Eby C, Raymund M, Zimmerman RK. (2010). Improving influenza vaccination rates in the workplace: a randomized trial. American journal of preventive medicine, 38(3)

Lee BY, Brown ST, Cooley P, Potter MA, Wheaton WD, Voorhees RE, Stebbins S, Grefenstette JJ, Zimmer SM, Zimmerman RK, Assi TM, Bailey RR, Wagener DK, Burke DS. (2010). Simulating school closure strategies to mitigate an influenza epidemic. Journal of public health management and practice : JPHMP, 16(3)

Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS. (2009). Age, revaccination, and tolerance effects on pneumococcal vaccination strategies in the elderly: a cost-effectiveness analysis. Vaccine, 27(24)

Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK, . (2009). Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 48(8)

Zimmerman RK, Nowalk MP, Lin CJ, Raymund M, Fox DE, Harper JD, Tanis MD, Willis BC. (2009). Factorial design for improving influenza vaccination among employees of a large health system. Infection control and hospital epidemiology, 30(7)

Nowalk MP, Tabbarah M, Terry MA, Raymund M, Wilson SA, Fox DE, Zimmerman RK, . (2009). Using quantitative and qualitative approaches to understand racial disparities in adult vaccination. Journal of the National Medical Association, 101(10)

Zimmerman RK, Nowalk MP, Tabbarah M, Hart JA, Fox DE, Raymund M, . (2009). Understanding adult vaccination in urban, lower-socioeconomic settings: influence of physician and prevention systems. Annals of family medicine, 7(6)

Nowalk MP, Tabbarah M, Hart JA, Fox DE, Raymund M, Wilson SA, Zimmerman RK, . (2009). Office manager and nurse perspectives on facilitators of adult immunization. The American journal of managed care, 15(10)

Zimmerman RK, Nowalk MP, Terry MA, Raymund M, Tabbarah M, Fox DE, Wilson SA. (2008). Assessing disparities in adult vaccination using multimodal approaches in primary care offices: methodology. Journal of urban health : bulletin of the New York Academy of Medicine, 85(2)

Zimmerman RK. (2009). An overview of the National Network for Immunization Information's website. Vaccine, 27(7)

Smith KJ, Zimmerman RK, Lin CJ, Nowalk MP, Ko FS, McEllistrem MC, Roberts MS. (2008). Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis. Vaccine, 26(11)

Zimmerman RK. (2007). Rationing of influenza vaccine during a pandemic: ethical analyses. Vaccine, 25(11)

Zimmerman RK, Tabbarah M, Nowalk MP, Raymund M, Wilson SA, McGaffey A, Wahrenberger JT, Block B, Ricci EM. (2007). Impact of the 2004 influenza vaccine shortage on patients from inner city health centers. Journal of urban health : bulletin of the New York Academy of Medicine, 84(3)

Zimmerman RK, Middleton DB. (2007). Vaccines for persons at high risk, 2007. The Journal of family practice, 56(2 Suppl Vaccines)

Zimmerman RK, Middleton DB, Burns IT, Clover RD, Kimmel SR. (2007). Routine vaccines across the life span, 2007. The Journal of family practice, 56(2 Suppl Vaccines)

Zimmerman RK. (2007). Recent changes in influenza vaccination recommendations, 2007. The Journal of family practice, 56(2 Suppl Vaccines)

Baker CJ, Schaffner W, Zimmerman RK. (2007). Importance of influenza vaccination for children. American family physician, 76(3)

Zimmerman RK. (2007). HPV vaccine and its recommendations, 2007. The Journal of family practice, 56(2 Suppl Vaccines)

Kimmel SR, Burns IT, Wolfe RM, Zimmerman RK. (2007). Addressing immunization barriers, benefits, and risks. The Journal of family practice, 56(2 Suppl Vaccines)

Zimmerman RK. (2006). Size of the needle for infant vaccination. BMJ (Clinical research ed.), 333(7568)

Zimmerman RK, Nowalk MP, Tabbarah M, Grufferman S. (2006). Predictors of colorectal cancer screening in diverse primary care practices. BMC health services research, (6)

Zimmerman RK, Tabbarah M, Janosky JE, Bardenheier B, Troy JA, Jewell IK, Yawn BP. (2006). Impact of vaccine economic programs on physician referral of children to public vaccine clinics: a pre-post comparison. BMC Public Health, (6)

Zimmerman RK. (2006). Ethical analysis of HPV vaccine policy options. Vaccine, 24(22)

Zimmerman RK, Tabbarah M, Nowalk MP, Raymund M, Jewell IK, Wilson SA, Ricci EM. (2006). Racial differences in beliefs about genetic screening among patients at inner-city neighborhood health centers. Journal of the National Medical Association, 98(3)

Zimmerman RK, Tabbarah M, Trauth J, Nowalk MP, Ricci EM. (2006). Predictors of lower endoscopy use among patients at three inner-city neighborhood health centers. Journal of urban health : bulletin of the New York Academy of Medicine, 83(2)

Zimmerman RK, Hoberman A, Nowalk MP, Lin CJ, Greenberg DP, Weinberg ST, Ko FS, Fox DE. (2006). Improving influenza vaccination rates of high-risk inner-city children over 2 intervention years. Annals of family medicine, 4(6)

Zimmerman RK, Wolfe RM, Fox DE, Fox JR, Nowalk MP, Troy JA, Sharp LK. (2005). Vaccine criticism on the World Wide Web. Journal of medical Internet research, 7(2)

Zimmerman RK, Tabbarah M, Bardenheier B, Janosky JE, Troy JA, Raymund M, Yawn BP. (2005). The 2002 United States varicella vaccine shortage and physician recommendations for vaccination. Preventive medicine, 41(2)

Zimmerman RK, Nowalk MP, Lin CJ, Ko FS, Block B, Anderson G, Wahrenberger JT, Fox DE. (2006). Interventions over 2 years to increase influenza vaccination of children aged 6-23 months in inner-city family health centers. Vaccine, 24(10)

Zimmerman RK. (2005). If pneumonia is the "old man's friend", should it be prevented by vaccination? An ethical analysis. Vaccine, 23(29)

Zimmerman RK. (2005). Time of hope for the eventual elimination of meningococcal strains A, C, Y, and W-135 in the United States. American family physician, 72(10)

Rust G, Strothers HS 3rd., Zimmerman RK. (2005). Re-engineering the primary care practice to eliminate adult immunization disparities. Ethnicity & disease, 15(2 Suppl 3)

Zimmerman RK, Tabbarah M, Nowalk MP, Raymund M, Jewell IK, Block B, Hall DG. (2005). Predictors of pneumococcal polysaccharide vaccination among patients at three inner-city neighborhood health centers. The American journal of geriatric pharmacotherapy, 3(3)

Tabbarah M, Nowalk MP, Raymund M, Jewell IK, Zimmerman RK. (2005). Barriers and facilitators of colon cancer screening among patients at faith-based neighborhood health centers. Journal of community health, 30(1)

Zimmerman RK, Middleton DB. (2005). Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005. The Journal of family practice, 54(1 Suppl)

Zimmerman RK, Middleton DB, Burns IT, Clover RD, Kimmel SR. (2005). Routine vaccines across the life span, 2005. The Journal of family practice, 54(1 Suppl)

Zimmerman RK. (2005). Recent changes in influenza epidemiology and vaccination recommendations. The Journal of family practice, 54(1 Suppl)

Burns IT, Zimmerman RK. (2005). Immunization barriers and solutions. The Journal of family practice, 54(1 Suppl)

Zimmerman RK, Hoberman A, Nowalk MP, Lin CJ, Greenberg DP, Weinberg ST, Bemm CW, Block B. (2004). Feasibility of influenza immunization for inner-city children aged 6 to 23 months. American journal of preventive medicine, 27(5)

Zimmerman RK. (2004). Ethical analyses of vaccines grown in human cell strains derived from abortion: arguments and Internet search. Vaccine, 22(31-32)

Zimmerman RK. (2004). Recommended Childhood and Adolescent Immunization Schedule, United States, January to June, 2004 and update on childhood immunizations. American family physician, 69(1)

Zimmerman RK, Nowalk MP, Bardella IJ, Fine MJ, Janosky JE, Santibanez TA, Wilson SA, Raymund M. (2004). Physician and practice factors related to influenza vaccination among the elderly. American journal of preventive medicine, 26(1)

Zimmerman RK, , , . (2003). The 2004 Recommended Adult Immunization Schedule. American family physician, 68(12)

Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. (2003). Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine, 21(13-14)

Zimmerman RK, Santibanez TA, Fine MJ, Janosky JE, Nowalk MP, Bardella IJ, Raymund M, Wilson SA. (2003). Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine, 21(13-14)

Zimmerman RK, Santibanez TA, Janosky JE, Fine MJ, Raymund M, Wilson SA, Bardella IJ, Medsger AR, Nowalk MP. (2003). What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. The American journal of medicine, 114(1)

Zimmerman RK, Middleton DB, Smith NJ. (2003). Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2003. The Journal of family practice, 52(1 Suppl)

Kimmel SR, Mahoney MC, Zimmerman RK. (2003). Vaccines and bioterrorism: smallpox and anthrax. The Journal of family practice, 52(1 Suppl)

Zimmerman RK, Nowalk MP, Raymund M, Tabbarah M, Hall DG, Wahrenberger JT, Wilson SA, Ricci EM. (2003). Tailored interventions to increase influenza vaccination in neighborhood health centers serving the disadvantaged. American journal of public health, 93(10)

Zimmerman RK, Nowalk MP, Santibanez TA, Jewell IK, Raymond M. (2003). Shortage of influenza vaccine in 2000-2001: did it change patient beliefs?. American journal of preventive medicine, 24(4)

Zimmerman RK, Middleton DB, Burns IT, Clover RD. (2003). Routine vaccines across the life span, 2003. The Journal of family practice, 52(1 Suppl)

Zimmerman RK. (2003). Recommended childhood and adolescent immunization schedule, United States, 2003 and update on childhood immunizations. American family physician, 67(1)

Kimmel SR, Burns IT, Zimmerman RK. (2003). Addressing immunization barriers, benefits, and risks. The Journal of family practice, 52(1 Suppl)

Clover RD, Zimmerman RK, . (2002). The 2003 Recommended Adult Immunization Schedule. Advisory Committee on Immunization Practices. American Academy of Family Physicians. American College of Obstetricians and Gynecologists. American College of Physicians. American Society of Internal Medicine. Centers for Disease Control and Prevention. American family physician, 66(12)

Zimmerman RK, Mieczkowski TA, Mainzer HM, Medsger AR, Nowalk MP. (2002). Understanding physician agreement with varicella immunization guidelines. Preventive medicine, 35(2)

Zimmerman RK. (2002). The 2002 recommended childhood immunization schedule and progress toward elimination of thimerosal. American family physician, 65(1)

Santibanez TA, Zimmerman RK. (2002). Immunizations in adulthood. Primary care, 29(3)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.